Abstract
Giving “old” viruses new “opportunities” may lead to biotechnology therapeutics
Similar content being viewed by others
Article PDF
References
Morse, Stephen, S. 1995. Factors in the emergence of infectious diseases. Emerging Infectious Disease 1: 7–15.
Duke, G., Osorio, J., and Palmenberg, A. 1990. Attenuation of Mengo virus through genetic engineering of the 5′ noncoding poly(C) tract. Nature 343: 474–6.
Osorio, J, Hubbard, G., Soike, K., Girard, M., van der Werf, S., Moulin, J.-C., and Palmenberg, A. 1995. Protection of non-murine mammals against encephatomyocarditits virus using a genetically engineered Mengo virus. Vaccine, in press.
Altmeyer, R., Escriou, N., Girard, M., Palmenberg, A., and van der Werf, S. 1994. Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc. Natl. Acad. Sci. USA 91: 9775–9779.
Efrat, S., Fejer, G., Brownlee, M., and Horwitz, M. 1995. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc. Natl. Acad. Sci U.S.A. 92: 6947–6951.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edgington, S. Using Viral Genes to Fight Disease. Nat Biotechnol 13, 1050–1055 (1995). https://doi.org/10.1038/nbt1095-1050
Issue Date:
DOI: https://doi.org/10.1038/nbt1095-1050